Pages that link to "Q34582741"
Jump to navigation
Jump to search
The following pages link to GnRH antagonist in assisted reproduction: a Cochrane review (Q34582741):
Displaying 50 items.
- Optimal usage of the GnRH antagonists: a review of the literature (Q21245566) (← links)
- The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS (Q28831013) (← links)
- Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. (Q30399747) (← links)
- Predictive factors for recovery time in patients suffering from severe OHSS. (Q33896863) (← links)
- Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? (Q34088817) (← links)
- Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo (Q34173433) (← links)
- Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol (Q34196524) (← links)
- The correlation between follicular fluid pregnancy-associated plasma protein A levels, fertilization, and embryo quality in GnRH agonist and GnRH antagonist protocols in ART cycles. (Q34216481) (← links)
- The efficacy of recombinant versus urinary HCG in ART outcome. (Q34217528) (← links)
- Comparison of ovulation induction protocols after endometrioma resection. (Q34401295) (← links)
- Cetrorelix in the treatment of female infertility and endometriosis (Q34571550) (← links)
- GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis (Q34573314) (← links)
- Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. (Q34604396) (← links)
- Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocol (Q34607007) (← links)
- GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. (Q34636679) (← links)
- GnRH antagonists: do they open new pathways to safer treatment in assisted reproductive techniques? (Q35049433) (← links)
- The luteal phase after ovarian stimulation. (Q35049436) (← links)
- Ovarian stimulation for IVF and endometrial receptivity--the missing link. (Q35049440) (← links)
- A short review of ovarian stimulation in assisted reproductive techniques (Q35123422) (← links)
- Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs (Q35123968) (← links)
- Prevention and treatment of ovarian hyperstimulation syndrome (Q35131919) (← links)
- GnRH antagonists in normal- responder patients (Q35165333) (← links)
- Antagonists in poor-responder patients (Q35165338) (← links)
- Patient-friendly ovarian stimulation (Q35203955) (← links)
- Safety of GnRH agonists and antagonists (Q35609748) (← links)
- Contemporary pharmacological manipulation in assisted reproduction (Q35660963) (← links)
- Assisted reproduction in the treatment of polycystic ovarian syndrome (Q35776464) (← links)
- Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI? (Q35808082) (← links)
- GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran. (Q36074736) (← links)
- Extrapituitary effects of GnRH antagonists in assisted reproduction: a review (Q36094997) (← links)
- Multiple birth resulting from ovarian stimulation for subfertility treatment (Q36135826) (← links)
- Safety of drugs used in assisted reproduction techniques (Q36144170) (← links)
- Emerging drugs in assisted reproduction (Q36150659) (← links)
- New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists (Q36249876) (← links)
- Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol (Q36268229) (← links)
- Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol (Q36268361) (← links)
- The effects of GnRH antagonist on the endometrium of normally menstruating women (Q36268633) (← links)
- Factors influencing response to ovarian stimulation (Q36367078) (← links)
- Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation? (Q36423212) (← links)
- Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles (Q36423226) (← links)
- FSH and folliculogenesis: from physiology to ovarian stimulation (Q36515505) (← links)
- Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis (Q36571890) (← links)
- The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome (Q36970286) (← links)
- Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol (Q36984419) (← links)
- Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study (Q37022407) (← links)
- Gonadotropin-releasing hormone in the ovary (Q37035786) (← links)
- Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes (Q37077680) (← links)
- Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection (Q37099563) (← links)
- IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study (Q37126409) (← links)
- Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation (Q37429879) (← links)